Royalty Pharma plc
NASDAQ: RPRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pablo Legorreta
- Employees
- 75
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $22.8B
- Website
- https://www.royaltypharma.com
Loading RPRX…
Loading profile data…Frequently asked questions about RPRX
What does Royalty Pharma plc (RPRX) do?
Royalty Pharma plc, headquartered in New York City and founded in 1996, operates within the United States as a key player in the biopharmaceutical industry. The company primarily focuses on the acquisition of royalties from biopharmaceutical products and actively invests in funding new developments and innovations in the sector. Its activities i...
Where does RPRX trade?
Royalty Pharma plc (RPRX) trades on the NASDAQ Global Select.
What sector is RPRX in?
Royalty Pharma plc (RPRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Royalty Pharma plc?
Pablo Legorreta is the chief executive officer of Royalty Pharma plc (RPRX).
Where is Royalty Pharma plc headquartered?
Royalty Pharma plc is headquartered in United States.
Does RPRX pay a dividend?
Yes — Royalty Pharma plc (RPRX) paid a trailing twelve-month dividend of USD 0.91 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did RPRX go public?
Royalty Pharma plc (RPRX) completed its initial public offering in 2020.